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Abstract  
 
Human cytomegalovirus (HCMV) is a widespread pathogen that infects up to 80% of 
the human population and causes severe complications in immunocompromised patients. 
HCMV expresses four seven transmembrane (7TM) spanning/G protein-coupled receptors 
(GPCRs) – US28, US27, UL33 and UL78 – that show close homology to human chemokine 
receptors. While US28 was shown to bind several chemokines and to constitutively activate 
multiple signaling cascades, the function(s) of US27, UL33 and UL78 in the viral life cycle 
have not yet been identified. Here we investigated the possible interaction/heteromerization of 
US27, UL33 and UL78 with US28 and the functional consequences thereof. We provide 
evidence that these receptors not only co-localize, but also heteromerize with US28 in vitro. 
While the constitutive activation of the US28-mediated Gαq/phospholipase C pathway was 
not affected by receptor heteromerization, UL33 and UL78 were able to silence US28-
mediated activation of the transcription factor NF-κB.  Summarized, we provide evidence that 
these orphan viral receptors have an important regulatory capacity on the function of US28 
and as a consequence, may ultimately impact on the viral life cycle of HCMV. 
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1. Introduction 
 
Human cytomegalovirus (HCMV), also known as human herpesvirus 5 (HHV-5), is a 
large and highly species-specific virus that belongs to the family of beta-herpesviruses. 
Infection with HCMV is asymptomatic and rarely causes complications in immunocompetent 
hosts. In immunosuppressed hosts, however, HCMV infection causes severe complications, 
including graft rejection or systemic infections [1-4]. HCMV expresses four viral seven 
transmembrane (7TM) spanning/G protein-coupled receptors (GPCRs), i.e. UL33 (unique 
long 33), UL78, US27 (unique short 27) and US28, which show high homology to human 
chemokine receptors [5, 6].  
 US28 is the best characterized HCMV encoded 7TM/GPCR and was suggested to i) be 
important for the viral life cycle by enhancing cell-cell fusion, thus promoting viral spread [7-
10] and ii) to activate the immediate early HCMV promoter, which generally leads to 
transactivation of other viral genes [11]. US28 is constitutively active – i.e. transduces signals 
in a ligand-independent way. The receptor activates the Gαq/phospholipase C (PLC) pathway 
and induces several transcription factors, such as NF-κB (nuclear factor kappa B), CREB 
(cyclic AMP responsive element binding) [12, 13], NFAT (nuclear factor of activated T cells) 
[14] or SRF (serum response factor) [15]. Moreover, US28 is constitutively endocytosed, 
which results in the localization of the receptor in the membranes of intracellular organelles, 
especially late endosomes/lysosomes and multi-vesicular bodies (MVBs) [13, 16, 17], where 
it has been suggested that the virions of HCMV may be assembled [7, 8]. 
 
 US27, UL33 and UL78 are still “orphan” receptors, since no endogenous ligands have 
been identified to date. Of these, UL33 was reported to constitutively induce inositol 
phosphate (IP) accumulation via coupling to Gαq and Gαi/o-proteins [13, 18] and to activate 
CREB via Gαq, Gαs, Gβγ and p38 kinase [13, 18], as well as to co-localize with endosomes  
Page 5 of 37
Ac
ce
pte
d M
an
us
cri
pt
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
5  
in HCMV infected cells [7, 8]. US27 was shown to be expressed during late HCMV infection 
states and found to be present on HCMV virions [7, 19, 20]. UL78 shares only very limited 
homology with endogenous chemokine receptors [21] and was shown to be dispensable for 
viral replication [22]. 
 Orphan 7TM/GPCRs have recently been shown to influence the signal activity of non-
orphan receptors through heteromerization. One prominent example is the orphan receptor 
GPR50, which was reported to antagonize the functions of the melatonin MT1 receptor. 
Heteromerization of GPR50 with the MT1 receptor prevented the agonist binding and G 
protein coupling [23].  
 Here we set out to test whether the orphan viral receptors US27, UL33 and UL78 
possibly interact/heteromerize with US28 and whether this had functional consequences on 
the signaling and/or endocytic properties of US28.  
 
 
2. Materials and Methods 
 
2.1 Reagents 
Mouse anti-Flag M1 and M2 monoclonal antibody, gelatine from bovine skin Type B, Triton 
X-100, 3, 3‟, 5, 5‟-Tetramethylbenzidine liquid substrate system were purchased from Sigma 
Aldrich (Austria). Cell culture media (DMEM), foetal bovine serum (FBS), Dulbecco‟s 
phosphate buffered saline (DPBS), Lipofectamine 2000, Alexa Fluor 594 nm conjugated 
IgG1a, 488 nm conjugated IgG2b and 594 nm conjugated donkey anti rabbit IgG were 
purchased from Invitrogen (Austria). HRP-conjugated anti-mouse antibody was obtained from 
Jackson Immuno Research (Dianova, Germany). Vectashield mounting medium and 
Vectastain ABC Kit were purchased from Vector Laboratories (Szabo-Scandic, Austria). The 
white 96-well culture plates and the Steadylite Plus Assay Kit, high sensitivity luminescence 
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reporter gene assay system, [
3
H]myo-inositol and EasyTag 
35
S-methionine were purchased 
from PerkinElmer (Austria). Yttrium silicate (YSi) SPA beads were from GE Healthcare 
(Austria). NaOH, KCl and CaCl2*2H2O were obtained from Merck (Austria), NaCl, Tris and 
Formaldehyde were from Roth (Lactan, Austria). Coelenterazine-h powder (1 mg) was 
purchased from Interchim (France). Monoclonal rat anti-HA and monoclonal mouse anti-GFP 
antibodies were purchased from Roche Diagnostics (France). Monoclonal rabbit anti-HA 
antibody was purchased from Cell signaling (France). Polyclonal rabbit anti-Flag antibody, 
protein G sepharose beads and poly-L-lysine were obtained from Sigma Aldrich (France). 
Phusion High-Fidelity DNA Polymerase was purchased from Finnzymes (France). IRdye 
800-conjugated anti-rat, IRdye 680-conjugated anti-rabbit, IRdye680-conjugated anti-mouse 
antibodies were purchased from Thermo Scientific (France). JetPEI transfection reagent was 
obtained from Polyplus Transfection (France).  
 
2.2 DNA constructs 
A Flag-tagged version of US28 (Flag-US28) was cloned by using the BamHI and XbaI 
restriction sites in the SS-Flag pcDNA3.1 zeo (+) vector (16). The cDNA encoding UL78 was 
kindly provided by Dr. Detlef Michel (University of Ulm, Germany) and was cloned in the 
SS-Flag pcDNA3.1 zeo (+) and SS-HA pcDNA3.1 zeo (+) vectors using BamHI and EcoRV 
restriction sites. UL33 (exon 1+2) was cloned in the SS-HA pcDNA3.1 zeo (+) vector using 
BamHI and XhoI restriction sites. A HA-tagged version of US27 (exon 2) was cloned by 
using the BamHI and EcoRV restriction sites in SS-HA pcDNA3.1 zeo (+) vector. Flag-
US28-YFP, HA-US28-Rluc, HA-UL33, HA-UL33-Rluc, Flag-UL78 and HA-UL78-Rluc 
constructs were obtained using the latter cDNAs as templates and the Phusion High-Fidelity 
DNA Polymerase. The Flag or HA tags were inserted after the ATG in frame of the US28, 
UL33 or UL78 sequences. Flag-US28, HA-US28, HA-UL33, Flag-UL78 and HA-UL78 were 
amplified by PCR. The amplified products were subcloned directly into a pCR2.1 vector 
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(Invitrogen, CA). After sequencing, the fragments were digested with the restriction enzymes 
HindIII and BamHI and subcloned into pcDNA3.1 vector or pcDNA3.1 vector containing 
either YFP or Rluc sequences. The vasopressin V2-YFP fusion protein has been described 
previously [24]. All DNA constructs were verified by sequencing. 
 
2.3 Antibody feeding experiments 
HEK293 cells were grown on gelatin coated coverslips and transiently transfected with Flag-
US28 (1.5 μg/coverslip) in combination with HA-UL33 (1.5 μg/coverslip), HA-UL78 (1.5 
μg/coverslip) or HA-US27 (1.5 μg/coverslip) using Lipofectamine 2000. 24 hours post-
transfection, antibody feeding experiments were conducted essentially as previously described 
[25]. In brief, living cells were incubated with anti-Flag M1 (1:500) and anti-HA HA11 
(1:500) antibodies for 45 minutes, fixed with 3.7 % formaldehyde in PBS and permeabilized 
in blotto (50 mM Tris-HCl, pH 7.5, 1 mM CaCl2, 0.2 % Triton X-100 and 3 % milk). 
Subsequently, the cells were stained with the subtype-selective antibodies Alexa Fluor 488-
conjugated IgG2b against the Flag-tag (1:1000, 20 minutes) and Alexa Fluor 594-conjugated 
IgG1a against the HA-tag (1:1000, 20 minutes). Finally, cells were mounted with Vecta shield 
mounting medium and analysed using a Olympus IX70 fluorescence microscope.  
 
2.4 Immunoprecipitation 
For co-immunoprecipitation assays, HEK293T cells were seeded in 10 cm dishes and co-
transfected with 8 g of the indicated plasmids. 48 hours after transfection, cells were washed 
twice in PBS, and lysed in 1 ml cold lysis buffer (25 mM Tris (pH 7.4), 2 mM EDTA, 10 mM 
MgCl2, protease inhibitor cocktail and 1 % Triton). After solubilization for 2 hours at 4 °C, 
lysates were centrifuged at 12 000 g during 1 hour at 4 °C and the supernatant was collected 
for the immunoprecipitation assay. Immunoprecipitations were performed using 2 µg of the 
indicated antibodies pre-adsorbed on protein G sepharose beads for 2 hours at 4 °C. 
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Immunoprecipitated proteins were eluted with Laemmli buffer 2X (Tris-HCl pH 6.8, 125 
mM, SDS 10 %, Glycerol 10 %, bromophenol blue 1 % and DTT 100 mM) and subjected to 
10 % or 7.5 % SDS–PAGE and immunoblotting. Immunoblotting was performed using the 
indicated antibodies and immunoreactivity was revealed using secondary antibodies coupled 
to 680 or 800 nm fluorophores using the Odyssey LI-COR infrared fluorescent scanner 
(ScienceTec). 
 
2.5 BRET (Bioluminescence resonance energy transfer) measurement  
HEK293T cells were grown in complete medium (Dulbecco‟s modified Eagle‟s medium 
supplemented with 10 % (v/v) fetal bovine serum, 4.5 g/L glucose, 100 U/mL penicillin, 0.1 
mg/mL streptomycin and 1 mM glutamine) (Invitrogen, CA). Transient transfections were 
performed using JetPEI transfection reagent according to manufacturer‟s instructions.  
For BRET donor saturation curves, HEK293T cells were seeded in 12-well plates and 
transiently transfected with 200 ng of HA-UL33-Rluc or 100 ng of HA-UL78-Rluc and 100 to 
1800 ng of YFP plasmids. For BRET competition assays, HEK293T cells were seeded in 6-
well plates. Cells were transiently transfected with (i) 200 ng HA-UL33-Rluc and 1000 ng 
Flag-US28-YFP in presence or absence of 1800 ng Flag-UL78 or (ii) 100 ng HA-UL78-Rluc 
and 1000 ng Flag-US28-YFP in presence or absence of 1900 ng HA-UL33 plasmids. 24 hours 
after transfection, cells were transferred into a 96-well white Optiplate pre-coated with 10 
mg/ml poly-L-lysine. Following 24 hours incubation, BRET measurements were conducted. 
Luminescence and fluorescence were measured simultaneously using the lumino/fluorometer 
Mithras
TM
 (Berthold) that allows the sequential integration of luminescence signals detected 
with two filter settings (Rluc filter, 485±10 nm; YFP filter, 530±12.5 nm). Emission signals at 
530 nm were divided by emission signals at 485 nm and the difference between this emission 
ratio (obtained with donor and acceptor fused or co-expressed and that obtained with the 
donor protein expressed alone) was defined as the BRET ratio. The results were expressed in 
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milliBRET units (mBU) corresponding to the BRET ratio values multiplied by 1000. Total 
fluorescence was measured with the fluorometer Fusion
TM
 (Packard Instrument Company). 
 
2.6 Reporter gene assays 
Transcription factor luciferase assays were performed essentially as described in [13]. In brief, 
HEK293 cells (30000 cells/well) were seeded on gelatin coated 96-well plates and transiently 
transfected with 75 ng/well Flag-US28, the cis-reporter plasmid for NF-κB (50 ng/well) and 
either pcDNA3.1 (75 ng/well) or the respective receptors (HA-UL33, HA-UL78 or HA-US27; 
75 ng/well). Controls were transfected with 150 ng/well of either pcDNA3.1 alone, or 
pcDNA3.1 (75 ng/well) in combination with UL33, UL78 or US27 (75 ng/well), but in the 
absence of US28. In parallel to each assay, an additional plate was prepared for ELISA (see 
below) to control for receptor expression levels. The luciferase reporter gene assays were 
conducted 24 hours post-transfection according to the manufacturer‟s guidelines. In brief, 
cells were washed twice with PBS and the cell number was determined by optical density in a 
FlexStation II Device (Molecular Probes, Endpoint Measurement). Then, 100 µl/well 
Steadylight luciferase assay reagent were added to 100 µl/ well PBS. Following a 10 min 
incubation period, luminescence was measured using a TopCounter Device (TopCount NXT, 
PerkinElmer).  
 
2.7 Inositol Phosphate (IP) accumulation assay  
HEK293 cells were seeded on gelatin coated 96-well plates (30000 cells/well) and transfected 
with 75 ng/well Flag-US28 and either pcDNA3.1 (75 ng/well) or the respective orphan 
receptor (HA-UL33, HA-UL78 or HA-US27; 75 ng/well). Controls were transfected with 
150ng/well of either pcDNA3.1 alone, or pcDNA3.1 (75 ng/well) in combination with UL33, 
UL78 or US27 (75 ng/well), but in the absence of US28. In parallel to each assay, an 
additional plate was prepared for ELISA (see below) to control for receptor expression levels.  
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24 hours post-transfection the cells were loaded with 1 μCi/well [3H]myo-inositol in 100 
μl/well Optimem and incubated overnight at 37 ºC and 5 % CO2. The next day, the labeling 
medium was aspirated, 100 μl/well HBSS buffer (including CaCl2 and MgCl2) containing 10 
mM LiCl were added and the cells were incubated for 45 minutes at 37 ºC and 5 % CO2. The 
reaction was terminated by aspiration and the cell number was determined by optical density 
in a FlexStation II Device. Subsequently, cells were lysed with 50 μl/well 10 mM formic acid 
for 90 minutes on ice. 40 μl of the resulting cell extract were transferred to 160 μl of YSi-SPA 
beads (12.5 mg/ml) and shaken for 90 minutes at 4ºC. The plates were then stored at 4ºC and 
the accumulation of inositol phosphate was counted in a TopCount microplate scintillation 
counter (TopCount NXT, PerkinElmer) 24 hours later.  
 
2.8 ELISA (enzyme linked immunosorbent assay) 
The ELISA assays were performed on the same day as the corresponding signaling 
experiments (see above). Cells were fixed with 3.7 % formaldehyde in PBS and permeabilized 
in blotto (50 mM Tris-HCl, pH7.5, 1 mM CaCl2, 0.2 % Triton X-100 and 3 % milk) for one 
hour. Next, the cells were incubated with either anti-Flag M1 (1:500) or anti-HA HA11 
(1:1000) antibody overnight at 4 °C. Then cells were washed with TBS (25 mM Tris base, 
135 mM NaCl, 2.5 mM KCl, 1 mM CaCl2*2H2O, pH 7.4) and incubated with HRP-
conjugated anti-mouse antibody (1:2500) in blotto (50 mM Tris-HCl, pH 7.5, 1 mM CaCl2 
and 1.5 % milk) for two hours at room temperature. After three washes with TBS, the cell 
number was determined by optical density in a FlexStation II Device. Then, 75 μl/well TMB 
(3, 3‟, 5, 5‟-Tetramethylbenzidine) substrate were added and the coloring reaction was 
stopped by the addition of 50 μl/well 0.5 M sulfuric acid after 2 minutes at room temperature. 
Receptor levels were measured at the optical density of 450 nm in a BioRad xMark 
Microplate Spectrophotometer.  
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2.9 Statistical analysis  
Statistical analyses were performed using ANOVA analysis of variance for comparisons 
between multiple groups, followed by a Bonferroni's post-hoc analysis using GraphPad Prism 
software.  
 
 
3. Results 
 
3.1 Co-localization of HCMV encoded chemokine receptors 
US28, UL33 and US27 have previously been shown to constitutively internalize and 
localize in intracellular compartments [7, 13, 16]. Here we set out to investigate a possible co-
localization of US28 with the three orphan HCMV encoded receptors US27, UL33 and UL78. 
Therefore, the respective receptors were transiently co-expressed with US28 in HEK293 cells 
at a 1:1 ratio and antibody feeding experiments were conducted (see methods). These 
experiments revealed that US28 co-internalizes and co-localizes with UL33 (Fig. 1A) and 
UL78 (Fig. 1B) in HEK293 cells. As described before [26], US28 was also found to co-
localize with US27 (Fig. 1C).  
 
3.2 Dimerization of US28 with US27, UL33 and UL78 
We were able to demonstrate that after constitutive internalization US28 co-localizes 
with all three orphan receptors in endosomal compartments (Fig. 1). Next, we conducted co-
immunoprecipitation (co-IP) experiments to test whether the receptors are not only co-
localizing, but furthermore able to physically interact with each other. Therefore, HEK293T 
cells were transiently co-transfected with Flag-US28-YFP and HA-US28 (A), HA-UL33-Rluc 
(B), HA-UL78-Rluc (C) or HA-US27 (D). These experiments revealed that US28 not only 
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12  
forms homomers (Fig. 2A), but moreover interacts with all three orphan receptors (Figs. 2B, C 
& D). 
 Next, Bioluminescence Resonance Energy Transfer (BRET) assays were performed to 
confirm the co-IP results. Therefore, UL33 or UL78 were fused at their C-terminus to Renilla 
luciferase (HA-UL33-Rluc, HA-UL78-Rluc) and used as energy donors. US28 was fused at its 
C-terminus to YFP (Flag-US28-YFP) and used as the energy acceptor. A possible 
heteromerization between US28 and US27 could not be validated using the BRET approach, 
since the co-expression of US27-Rluc led to a significant decrease in US28-YFP expression 
levels (data not shown). 
 Donor saturation curves were performed by co-transfecting a fixed amount of HA-
UL33-Rluc or HA-UL78-Rluc in the presence of increasing amounts of Flag-US28-YFP in 
HEK293T cells. The vasopressin V2 receptor YFP (V2-YFP) fusion protein was used as a 
negative control. A specific interaction between BRET donor and acceptor pairs is reflected 
by a hyperbolic donor saturation curve, which reaches an asymptote with increasing 
YFP/Rluc ratios. This is shown for the US28/UL33 couple (Fig. 3A) and the US28/UL78 
couple (Fig. 3B), respectively. In contrast, a non-specific interaction, due to random collision, 
was observed with V2-YFP where a quasi-linear increase in BRET was observed with 
increasing YFP/Rluc ratios (Fig. 3B). BRET competition assays were then performed to 
assess, if UL78 and UL33 can disrupt US28/UL33 and US28/UL78 heteromerization, 
respectively. The YFP/Rluc ratio in the ascending portion of the saturation curve before the 
plateau was selected and the corresponding amounts of donor and acceptor plasmids were 
transfected in the presence of saturating amounts of the competitor receptor (Flag-UL78 in the 
case of HA-UL33-Rluc/Flag-US28-YFP and HA-UL33 in the case of HA-UL78-Rluc/Flag-
US28-YFP). The BRET signal was significantly decreased in the presence of the competitor 
receptor indicating that UL78 (Fig. 3C) and UL33 (Fig. 3D) interfere with US28/UL33 and 
US28/UL78 heteromerization, respectively. 
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Summarized, the co-IP and BRET experiments show that US28 forms homomers and 
is furthermore able to heteromerize with the three viral HCMV encoded receptors US27, 
UL33 and UL78.  
 
3.3 US28-mediated transcription factor activation, but not G protein-mediated inositol 
phosphate accumulation, is altered by receptor heteromerization 
It has previously been demonstrated that receptor heteromerization alters the trafficking and 
signaling properties of 7TM/GPCRs [27-29]. Importantly, orphan receptors – such as GPR50 
- have been demonstrated to modulate the activity of non-orphan receptors through 
heteromerization [30].  
Hence, we next tested the functional consequences of the heteromerization of US28 
with US27, UL33 and UL78. First, the ability of US28 to mediate the Gαq/phospholipase C 
(PLC) dependent accumulation of inositol phosphate (IP) was assessed in cells co-expressing 
the orphan HCMV encoded receptors. US28 constitutively induced IP turnover in the absence 
(Figs. 4 A, D & G, black bars) and presence (Figs. 4 A, D & G, grey bars) of the other viral 
receptors. The expression levels of Flag-tagged US28 (Figs. 4 B, E & H) as well as the HA-
tagged orphan receptors (Figs. 4 C, F & I) were monitored by ELISA. These results suggest 
that the orphan receptors had no direct influence on the G protein mediated signaling capacity 
of US28.  
US28 has been reported to activate downstream transcription factors such as NF-κB, 
CREB [12, 13], NFAT [14] or SRF [15]. We next tested whether the heteromerization of 
US28 with the orphan HCMV encoded receptors alters the downstream signal transduction 
profile of US28. Hence, US28 was co-expressed with the respective orphan receptors and 
reporter gene assays were performed. Interestingly, the co-expression of UL33 and UL78 
were found to significantly decrease the activation of the transcription factor NF-κB by US28 
(Figs. 5A & 5D, compare black bars vs. grey bars). The reduction of US28 signaling capacity 
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in the presence of UL33 and UL78 was unlikely to be due to altered expression levels of the 
receptors, since they remained relatively stable under the different experimental conditions 
(see Figs. 5B, C, E & F). Co-expression of US27 on the other hand, did not alter the signaling 
capacity of US28 (Fig. 5G compare black bar vs. gray bar). 
Summarized, these data suggest that the constitutive signaling activity of US28 is 
selectively modulated via heteromerization with the orphan HCMV-encoded UL33 and UL78. 
The activation of the Gαq/PLC/IP3 pathway via US28 was not altered, whereas the activation 
of the transcription factor NF-κB by US28 was almost completely blocked by UL33 or UL78, 
respectively. 
 
 
4. Discussion 
 
Out of the four HCMV encoded 7TM/GPCRs, US28 is the only receptor that has been 
shown to bind endogenous chemokines [13, 31, 32]. The other three receptors - US27, UL33 
and UL78 - are yet orphan receptors with mainly unknown function [5, 6]. Here we tested 
whether these orphan receptors – similar to recent reports on other orphan 7TM/GPCRs  [[23] -  
may have ligand-independent functions by modulating the signaling and trafficking capacities 
of US28.  
Antibody feeding experiments revealed that all four viral 7TM/GPCRs are 
predominantly found in intracellular compartments. This is in accordance with previous data on 
US27, US28 and UL33 [[7, 33], which have all been described to constitutively internalize. 
Here we show for the first time that US28 co-localizes with all three orphan receptors in 
HEK293 cells (Fig. 1).  
Heteromerization and thus a direct protein-protein interaction between these HCMV 
encoded receptors were confirmed by co-IP and BRET experiments (Figs. 2 & 3). To date it is 
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widely accepted that most, if not all, 7TM/GPCRs are organized in dimeric/oligomeric 
complexes. The importance of 7TM/GPCR oligomerization is most convincingly illustrated by 
the functional alterations induced when two different 7TM/GPCRs associate to form 
heteromeric complexes. Modifications in pharmacological, signaling and trafficking properties 
have been observed for many 7TM/GPCRs when engaged into heteromers [27-29, 34]. For 
instance, the chemokine receptor CXCR4 was shown to heteromerize with CCR5 [35, 36], 
whereby the CCR5/CXCR4 heteromer was causally involved in the modulation of T 
lymphocyte responses [37]. Moreover, homomerization of CCR5 was shown to prevent 
infection with HIV-1 [38]. 
In addition, orphan receptors were shown to be capable of influencing the activity of 
non-orphan receptors through heteromerization. The orphan receptor GPR50, for example, 
was reported to antagonize the functions of the melatonin MT1 receptor via heteromerization. 
Heteromerization of GPR50 with the MT1 receptor prevented the agonist binding and G 
protein coupling [23]. Moreover, it was found that the carboxy-terminus of GPR50 is 
involved in these inhibitory effects. As opposed to the wild type receptor, heteromerization 
with a carboxy-terminally deleted GPR50 did not alter MT1 related functions [23]. 
To evaluate the functional consequences of viral HCMV receptor heteromerization, 
the Gαq/PLC/IP pathway and the activation of the downstream transcription factor NF-κB 
were monitored. Surprisingly, the IP accumulation was not altered upon co-expression of 
US28 with the orphan receptors (Fig. 4). On the other hand, the constitutive activation of NF-
κB was almost completely blocked by the co-expression of UL33 (Fig. 5A) and UL78 (Fig. 
5D). US27, the HCMV encoded receptor that shares the highest sequence homology with 
US28, did neither alter the IP accumulation (Fig. 4G), nor the activation of the transcription 
factor (Fig. 5G).  
The NF-κB pathway is known to be an important regulator of the innate and the 
adaptive immune response, inflammation and cell survival [39]. The major immediate early 
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promoter (MIEP) region of HCMV, which controls the expression of immediate early (IE) 
genes, contains four binding sites for the transcription factor NF-κB. The role of these binding 
sites is not completely established. In some studies, inhibition of NF-κB signaling yielded an 
impaired viral replication [40, 41], whereas other reports show that the deletion of the binding 
sites within the MIEP region had no effects [42, 43]. The mechanisms employed by HCMV 
for the establishment of viral latency and reactivation are still an important source of 
speculation.  In general, HCMV infection and reactivation were shown to yield the 
enhancement of cellular responses, including the activation of transcription factors, 
accumulation of cAMP, inositol phosphate hydrolysis and the metabolism of arachidonic acid 
[44, 45]. For γ-herpesviruses, such as KSHV (Kaposi‟s sarcoma-associated herpesvirus), EBV 
(Epstein-Barr virus) or γ-herpesvirus 68 (γ-HV68), the NF-κB pathway was reported to be 
involved in cell growth as well as in the establishment of viral latency [46-50]. Hence, it is 
tempting to speculate that the selective modulation of the NF-κB activation via 
heteromerization with US28 might be important in viral reactivation or latency. Indeed, 
heteromerization of US28 and UL78, which is co-expressed during the early phases of HCMV 
infection, could provide a way to downregulate the NF-κB activation of US28. In addition, 
during late stages of HCMV infection, the constitutive activity of US28 could be modulated 
via heteromerization with UL33. After the initial re-programming of newly infected cells, the 
downregulation of US28 via heteromerization with the orphan receptors UL33 and UL78 
might thus represent a mechanism to negatively modulate the NF-κB pathway.  
Recent reports suggest that US28 might play a causative role in multiple diseases 
associated with HCMV infection. Human cytomegalovirus has been shown to be present in 
various malignancies, including breast cancer [51], colon cancer [52] or malignant 
glioblastoma [53]. Indeed, US28 seems to be involved in tumorigenesis via the up-regulation 
of COX-2 [54, 55]. Moreover, Bongers and co-workers showed that the receptor also 
promotes intestinal neoplasia and cancer in transgenic mice [56] . In addition, US28 might 
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also represent the causative link between HCMV infection and the accelerated progression of 
vascular diseases, since it is able to mediate the migration of vascular smooth muscle cells 
[57].  
Hence, the finding that US28 is engaged in hetero-/oligomeric complexes provides 
important information for future drug design. Furthermore, the manipulation of the NF-κB 
pathway via heteromerization with the other HCMV encoded receptors might contribute to 
understanding the mechanisms underlying viral latency and reactivation in vivo. 
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Figure captions 
 
Figure 1. US28 co-localizes with UL33, UL78 and US27.  HEK293 cells transiently 
transfected with Flag-US28 and either HA-UL33 (A), HA-UL78 (B) or HA-US27 (C) were 
‘fed’ antibody to the extracellular Flag-tag and HA-tag for 60 minutes. The cells were then 
fixed and stained with the secondary antibodies under permeabilizing conditions. Finally, 
cells were mounted with vectashield (+DAPI, blue) and analyzed by fluorescence microscopy. 
Merge: yellow. Scale bars = 10 µm. 
 
Figure 2 A. Detection of US28/US28 homomers using co-immunoprecipitation. HEK293T 
cells were transfected with HA-US28 in the presence or absence of Flag-US28-YFP. Lysates 
were immunoblotted with monoclonal rabbit anti-HA (bottom blot) and polyclonal rabbit anti-
Flag antibodies (middle blot). Lysates were immunoprecipitated with monoclonal rat anti-HA, 
resolved by SDS–PAGE and immunoblotted with polyclonal rabbit anti-Flag antibodies (top 
blot). B. Detection of US28/UL33 heteromers using co-immunoprecipitation. HEK293T 
cells were transfected with HA-UL33-Rluc in the presence or absence of Flag-US28-YFP. 
The expression of HA-UL33-Rluc was monitored by measuring Renilla luciferase activity 
following coelenterazine H addition (bottom graph). Lysates were immunoblotted with 
monoclonal mouse anti-GFP antibodies (middle blot). Lysates were immunoprecipitated with 
monoclonal rat anti-HA, resolved by SDS–PAGE and immunoblotted with monoclonal mouse 
anti-GFP antibodies (top blot). C. Detection of US28/UL78 heteromers using co-
immunoprecipitation. HEK293T cells were transfected with HA-UL78-Rluc in the presence 
or absence of Flag-US28-YFP. The expression of HA-UL78-Rluc was monitored by 
measuring Renilla luciferase activity following coelenterazine H addition (bottom graph).  
Lysates were immunoblotted with polyclonal rabbit anti-Flag antibodies (middle blot). 
Table
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Lysates were immunoprecipitated with monoclonal rat anti-HA, resolved by SDS–PAGE and 
immunoblotted with polyclonal rabbit anti-Flag antibodies (top blot). All immunoblots shown 
are representative of three independent experiments. D. Detection of US28/US27 heteromers 
using co-immunoprecipitation. HEK293T cells were transfected with HA-US27 in the 
presence or absence of Flag-US28-YFP to assess US27/US28 heteromer formation. Lysates 
were immunoblotted with monoclonal rat anti-HA (bottom blot) and polyclonal rabbit anti-
Flag antibodies (middle blot). Lysates were immunoprecipitated with monoclonal rat anti-HA, 
resolved by SDS–PAGE and immunoblotted with polyclonal rabbit anti-Flag antibodies (top 
blot). 
 
Figure 3. Heteromerization of US28 with UL33 and UL78. A. Donor saturation curves 
were performed by co-transfecting a fixed amount of HA-UL33-Rluc in presence of 
increasing amounts of Flag-US28-YFP in HEK 293T cells. The saturation curves are obtained 
from three independent experiments. B. Donor saturation curves were performed by co-
transfecting a fixed amount of HA-UL78-Rluc in presence of increasing amounts of Flag-
US28-YFP (●) in HEK 293T cells. V2-YFP (■) was used as a negative control. The saturation 
curves are obtained from three independent experiments. C. Bret competition assays were 
performed by co-transfecting a fixed amount of HA-UL33-Rluc and Flag-US28-YFP 
corresponding to a YFP/Rluc ratio in the ascending portion of the saturation curve before the 
plateau in presence of saturating amounts of the competitor receptor (Flag-UL78). Lysates 
were immunoblotted with polyclonal rabbit anti-Flag antibody (bottom blot) to assess the 
expression levels of the competitor receptor. D. Bret competition assays were performed by 
co-transfecting a fixed amount of HA-UL78-Rluc and Flag-US28-YFP corresponding to a 
YFP/Rluc ratio in the ascending portion of the saturation curve before the plateau in presence 
of saturating amounts of the competitor receptor (HA-UL33). Lysates were immunoblotted 
with monoclonal rabbit anti-HA antibody (bottom blot) to assess the expression levels of the 
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competitor receptor. Statistical differences were assessed using the student t-test (***p 
<0.001). 
 
Figure 4. US28-mediated inositol phosphate (IP) accumulation is not altered by 
heteromerization with UL33, UL78 or US27. A, D & G. IP accumulation in HEK293 
cells co-expressing receptor heteromers. HEK293 cells were transiently transfected with 
Flag-US28 (75 ng/well) and either pcDNA3.1 (black bars, 75 ng/well) or 75ng/well of HA-
UL33 (A), HA-UL78 (D) or HA-US27 (G), respectively (grey bars). Controls were 
transfected with either pcDNA3.1 alone (150 ng/well, white bars) or pcDNA3.1 (75 ng/well) 
in combination with 75 ng/well of HA-UL33 (A), HA-UL78 (D) or HA-US27 (G) (striped 
bars) in the absence of Flag-US28. IP production mediated by US28 was allowed to 
accumulate for 45 minutes. Values were normalized to the cell number, and 100% 
corresponds to the basal activity of US28 (black bars). Data are means of four experiments ± 
SEM carried out in quadruplicates. B, C, E, F, H & I. Receptor expression levels evaluated 
by ELISA. HEK293 cells were transfected as described for the respective IP accumulation 
assay. The expression levels of US28 were assayed by ELISA against the Flag epitope tag of 
US28 (B, E & H). The levels of UL33 (C), UL78 (F) and US27 (I) were assessed by ELISA 
against the HA epitope tag of the respective receptors. Values were normalized to the cell 
number. Data are means ± SEM of four independent experiments carried out in 
quadruplicates.  
 
Figure 5. UL33 and UL78 alter US28 mediated NF-κB activation. A, D & G. NF-κB 
activation in HEK293 cells co-expressing receptor heteromers. HEK293 cells were 
transiently transfected with Flag-US28 (75 ng/well), the cis-reporter luciferase plasmid for 
NF-κB (50 ng/well) and either pcDNA3.1 (black bars, 75 ng/well) or 75ng/well of HA-UL33 
(A), HA-UL78 (D) or HA-US27 (G), respectively (grey bars). Controls were transfected with 
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either pcDNA3.1 alone (150 ng/well, white bars) or pcDNA3.1 (75 ng/well) in combination 
with 75 ng/well of HA-UL33 (A), HA-UL78 (D) or HA-US27 (G) (striped bars) in the 
absence of Flag-US28. A luciferase reporter assay was conducted 24 hours post-transfection. 
Values were normalized to the cell number, whereby 100% corresponds to the basal activity 
of US28 (black bars). Data are means of three independent experiments ± SEM carried out in 
quadruplicates. *** P<0.001. B, C, E, F, H & I. Receptor expression levels evaluated by 
ELISA. HEK293 cells were transfected as described for the respective NF-κB assay. The 
expression levels of US28 were assayed by ELISA against the Flag epitope tag of US28 (B, E 
& H). The levels of UL33 (C), UL78 (F) and US27 (I) were assessed by ELISA against the 
HA epitope tag of the respective receptors. Values were normalized to the cell number. Data 
are means ± SEM of four independent experiments carried out in quadruplicates.  
 
Page 29 of 37
Ac
ce
pte
d M
an
us
cri
pt
Figure
Click here to download high resolution image
Page 30 of 37
Ac
ce
pte
d M
an
us
cri
pt
Figure
Click here to download high resolution image
Page 31 of 37
Ac
ce
pte
d M
an
us
cri
ptFigureClick here to download high resolution image
Page 32 of 37
Ac
ce
pte
d M
an
us
cri
pt
Figure
Click here to download high resolution image
Page 33 of 37
Ac
ce
pte
d M
an
us
cri
ptFigureClick here to download high resolution image
Page 34 of 37
Ac
ce
pte
d M
an
us
cri
ptFigureClick here to download high resolution image
Page 35 of 37
Ac
ce
pte
d M
an
us
cri
ptFigureClick here to download high resolution image
Page 36 of 37
Ac
ce
pte
d M
an
us
cri
ptFigureClick here to download high resolution image
Page 37 of 37
Ac
ce
pte
d M
an
us
cri
pt*Graphical AbstractClick here to download high resolution image
